Orthofix Medical/$OFIX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Orthofix Medical

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

Ticker

$OFIX
Primary listing

Industry

Health Care Equipment & Supplies

Employees

1,616

ISIN

US68752M1080

Orthofix Medical Metrics

BasicAdvanced
$445M
-
-$3.72
0.88
-

What the Analysts think about Orthofix Medical

Analyst ratings (Buy, Hold, Sell) for Orthofix Medical stock.

Bulls say / Bears say

Orthofix Medical reported record fourth-quarter 2024 net sales of $215.7 million, an 8% increase from the previous year, indicating strong market demand for its products. (biospace.com)
The company's Bone Growth Therapies segment achieved net sales of $63.9 million in Q4 2024, marking a 9% growth and reflecting sustained demand in this product line. (biospace.com)
Orthofix increased its long-term net sales compound annual growth rate target to 6.5%-7.5%, up from the previous 6%-7%, signaling confidence in future growth prospects. (biospace.com)
Despite revenue growth, Orthofix reported a net loss of $29.1 million in Q4 2024, indicating ongoing profitability challenges. (biospace.com)
The company's Altman Z-score of 1.59 places it in the distress zone, suggesting a higher risk of financial distress within the next two years. (gurufocus.com)
Orthofix's debt-to-revenue ratio stands at 0.17, which, while not excessively high, indicates a reliance on debt that could impact financial flexibility. (gurufocus.com)
Data summarised monthly by Lightyear AI. Last updated on 10 Jul 2025.

Orthofix Medical Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Orthofix Medical Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $OFIX

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs